Video Series
Please check back later for more content.
Advertisement
Advertisement
Trending on Patient Care Online
1
Semaglutide’s Setback in Alzheimer Disease Trials: Commentary on Outcomes of evoke and evoke+
2
CTAD 2025: Lecanemab Boosts CSF Aβ Protofibrils, Confirming Target Engagement and Pharmacodynamic Effect
3
“There’s Always Something We Can Do" for Agitation in Alzheimer Disease, Says Carolyn Clevenger, GNP
4
Lifestyle Intervention Shows Benefits Beyond Cognition in US POINTER Trial, Highlighting Modifiable Risk Factors for Dementia
5
